MONDAY, Jan. 22 (HealthDay News) -- The identification by U.S.
scientists of
Cells called regulatory T-cells are supposed to help keep the immune system in check, but in autoimmune disease, these mechanisms can fail.
Now, researchers reporting this week in the journal
Nature have identified a set of genes closely linked to
regulatory T-cell function. The finding could have important
implications for research into autoimmune disease and even
"This is certainly important in trying to understand how these regulatory T-cells work," said Dr. Noel Rose, director of the Johns Hopkins Center for Autoimmune Disease Research in Baltimore. "Whether this will have important functional implications, only time will tell," said Rose, who was not involved in the study.
Though it is meant to shield our bodies from all pathogens
foreign and domestic,
Both of these situations are linked to the immune system's fundamental purpose: to distinguish the body's own cells (and related entities) from foreign invaders. So, cancer cells are ignored by the immune system because they are determined to be the body's own cells. Autoimmune disorders arise when the immune system gets confused and attacks healthy tissues.
In this study, researchers from Harvard Medical School, the
Dana-Farber Cancer Institute, the Massachusetts Institute of
Technology, and the
They focused on a protein that is found only in regulatory T-cells, called Foxp3. Foxp3 is a transcription factor -- that is, it dials up or down the production of other genes. Its significance in controlling the immune system is underscored by the fact that people with mutant Foxp3 genes develop IPEX, a syndrome marked by massive autoimmune disorders and early mortality.


















